We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+9.13%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.03B
AUM Growth
-$383M
Cap. Flow
-$421M
Cap. Flow %
-40.89%
Top 10 Hldgs %
24.29%
Holding
2,439
New
893
Increased
254
Reduced
276
Closed
993

Sector Composition

Rank Sector Weight
1 Technology 10.93%
2 Healthcare 10.76%
3 Consumer Discretionary 9.35%
4 Communication Services 9.1%
5 Financials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMVC.WS
1426
DELISTED
PMV Consumer Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PMVC.WS
$11K ﹤0.01%
+12,982
New +$10.4K
SDEV
1427
Stablecoin Development Corp
SDEV
$52M
$9K ﹤0.01%
2
-3
-60% -$13.7K
HYMCZ
1428
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCZ
$9K ﹤0.01%
+18,184
New +$7.33K
NSPRZ
1429
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$9K ﹤0.01%
48,129
+24,681
+105% +$1.64K
PTK.WS
1430
DELISTED
PTK Acquisition Corp. Warrants, each whole warrant exercisable for one half (1/2) of a share of Comm
PTK.WS
$9K ﹤0.01%
+16,381
New +$9.74K
CRXTW
1431
DELISTED
Clarus Therapeutics Holdings, Inc. Warrants
CRXTW
$8K ﹤0.01%
+11,077
New +$6.95K
VENAR
1432
DELISTED
Venus Acquisition Corporation Rights
VENAR
$7K ﹤0.01%
+11,505
New +$4.78K
GSMGW
1433
DELISTED
Cheer Holding, Inc. Warrant expiring 2/13/2025
GSMGW
$5K ﹤0.01%
32,720
+19,676
+151% +$2.75K
ESSCW
1434
DELISTED
East Stone Acquisition Corporation Warrant
ESSCW
$5K ﹤0.01%
16,383
-26,838
-62% -$6.66K
ONTXW
1435
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$5K ﹤0.01%
+27,719
New +$5.72K
NSPRW
1436
DELISTED
InspireMD, Inc. Warrants
NSPRW
$4K ﹤0.01%
19,402
+7,251
+60% +$853
CETXW
1437
DELISTED
Cemtrex Inc. Series 1 Warrant
CETXW
$3K ﹤0.01%
26,781
+5,536
+26% +$720
AA icon
1438
Alcoa
AA
$13.8B
-12,895
Closed -$419K
A icon
1439
Agilent Technologies
A
$42.1B
-3,801
Closed -$483K
AAP icon
1440
Advance Auto Parts
AAP
$3.2B
-3,288
Closed -$603K
ABCB icon
1441
Ameris Bancorp
ABCB
$5.94B
-4,414
Closed -$232K
ABEV icon
1442
Ambev
ABEV
$43.9B
-291,790
Closed -$800K
ABT icon
1443
Abbott
ABT
$192B
-7,373
Closed -$884K
ACMR icon
1444
ACM Research
ACMR
$5.77B
-8,463
Closed -$228K
ACM icon
1445
Aecom
ACM
$7.99B
-4,541
Closed -$291K
ACN icon
1446
Accenture
ACN
$109B
-3,667
Closed -$1.01M
ZNB
1447
Zeta Network Group
ZNB
$2.52M
0
-$236K
ADI icon
1448
Analog Devices
ADI
$188B
-12,732
Closed -$1.97M
ADN
1449
DELISTED
Advent Technologies
ADN
-788
Closed -$317K
ADPT icon
1450
Adaptive Biotechnologies
ADPT
$3.98B
-14,579
Closed -$587K

Similar funds

Virtu Financial's Q2 2021 Portfolio in Review

As of Q2 2021, Virtu Financial held 2,439 positions worth $1.03B, down 27% from $1.41B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Virtu Financial withdrew a net $421M in Q2 2021, closing 993 positions and reducing 276 holdings. Its most notable exit was SPDR Gold Trust, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Virtu Financial opened a new position in PRA Health Sciences, Inc. worth $111M.

  • Virtu Financial's largest Q2 2021 buy was PRA Health Sciences, Inc.: 668,921 shares worth $111M.
  • Virtu Financial added most to Alphabet (Google) Class A in Q2 2021, an estimated $16.1M increase.
  • Virtu Financial's biggest Q2 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $56.6M.
  • Virtu Financial fully exited SPDR Gold Trust in Q2 2021, selling an estimated $213M.
  • Virtu Financial's ten largest holdings make up 24% of its $1.03B portfolio in Q2 2021.
  • Virtu Financial opened 893 new positions and closed 993 in Q2 2021.
  • Virtu Financial's portfolio value fell 27% quarter-over-quarter to $1.03B.

Based on Virtu Financial's 13F filing for Q2 2021, filed 17 Sep 2021.